Qihan Biotech
PrivateLast Round
VC Round
Sep 22, 2023
Total Funding Raised
$100.3M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Qihan Biotech is a biotechnology company that develops off-the-shelf cell therapies and xenogeneic organs using multiplex genome editing technology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Qihan Biotech Comparables
Compare Qihan Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Neukio Biotherapeutics | 85% | |
| Adicet Bio | 78% | |
| Allogene Therapeutics | 77% |
Qihan Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Sep 22, 2023 | ||||
| Series A Extension | Mar 29, 2021 | ||||
| Series A Extension | Sep 23, 2019 | ||||
| Series A | Jul 23, 2018 |
Qihan Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Matrix | VC Round, Series A Extension |
| Legend Star | Series A Extension |
| 招银国际金融有限公司 | Series A Extension |
| BC Partners | Series A Extension |
| ARCH Venture Partners | Series A |
| Northern Light Venture Capital | Series A, Series A Extension, VC Round |
| Biomatics Capital Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 369% MoM, reaching 9.8K.
- Jul 24, 2026
Monthly visitors grew 300% MoM, reaching 2.1K.
Qihan Biotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Qihan Biotech's valuation, stock price, and market status.
Is Qihan Biotech a public or private company?
Qihan Biotech is a private company.
What is the current stock price of Qihan Biotech?
Qihan Biotech is a private company, so its shares have no public market price. Caplight tracks Qihan Biotech's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Qihan Biotech worth (valuation)?
Valuation information for Qihan Biotech is not publicly available.
Can I buy Qihan Biotech stock?
Qihan Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Qihan Biotech's last funding round?
Qihan Biotech's most recent funding round was VC Round on September 22, 2023.
Who are the main investors in Qihan Biotech?
Key investors in Qihan Biotech include Matrix, 招银国际金融有限公司, Sequoia Capital, Zhejiang Financial Holding, Lilly Asia Ventures.
Will Qihan Biotech IPO soon?
No public IPO plans have been announced for Qihan Biotech.
How can I track Qihan Biotech secondary market activity?
Caplight tracks bids, offers, and trades in Qihan Biotech's shares on secondary markets.